Michael Richman - 21 Jun 2023 Form 4 Insider Report for PIERIS PHARMACEUTICALS, INC. (PVLA)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PIRS	Stock Option (right to buy)	Award	$0	+40,000		$0.000000	40,000	21 Jun 2023	Common Stock	40,000	$0.2600	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The stock option will vest as to 100% of the underlying shares on the date of the Company's 2024 annual stockholders meeting, subject to the Reporting Person's continued service as a director through the vesting date.